No definition available.

Name:	rfl_IssuedAndOutstandingOrdinarySharesPercentage
Namespace Prefix:	rfl_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Sum of investments and unrestricted cash as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

+ Details

Name:	us-gaap_InvestmentsAndCash
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The parent entity's interest in net assets of the subsidiary, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of capital contributed by other unit holders.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 4.F)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-8

+ Details

Name:	us-gaap_OtherOwnershipInterestsValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	srt_OwnershipAxis=rfl_LipomedixPharmaceuticalsLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=rfl_RafaelMedicalDevicesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=rfl_CSPharmaHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=rfl_PharmaHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=rfl_CSPharmaHoldingsLLCOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Description of Business (Details) - USD ($)	Mar. 13, 2024	Apr. 30, 2026	Feb. 28, 2025	Aug. 31, 2023
Description of Business [Line Items]
Percentage of issued and outstanding	67.00%
Company raised from third parties (in Dollars)				$ 925,000
Investments cash (in Dollars)			$ 582,000
Lipomedix Pharmaceuticals Ltd. [Member]
Description of Business [Line Items]
Equity interest		95.00%
Rafael Medical Devices, Inc. [Member]
Description of Business [Line Items]
Equity interest			73.00%	31.60%
Company raised from third parties (in Dollars)			$ 45,000
CS Pharma Holdings, LLC [Member]
Description of Business [Line Items]
Equity interest		50.00%
Pharma Holdings, LLC [Member]
Description of Business [Line Items]
Equity interest		90.00%
Pharma Holdings, LLC [Member] \| Business Combination [Member]
Description of Business [Line Items]
Equity interest		67.00%
CS Pharma Holdings, LLC One [Member]
Description of Business [Line Items]
Equity interest		45.00%